Benefit of vutrisiran in transthyretin amyloidosis with cardiomyopathy
Crossref DOI link: https://doi.org/10.1038/s41569-024-01086-y
Published Online: 2024-09-19
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lim, Gregory B.
Text and Data Mining valid from 2024-09-19
Version of Record valid from 2024-09-19
Article History
First Online: 19 September 2024